These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6588670)

  • 1. Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP).
    Tomirotti M; Riundi R; Pulici S; Ungaro A; Pedretti D; Villa S; Scanni A
    Tumori; 1984 Jun; 70(3):235-6. PubMed ID: 6588670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of cardiac function in anthracycline therapy in childhood].
    Jensen E; Richter R; Mittler U; Kluba U; Aumann V
    Padiatr Grenzgeb; 1984; 23(6):455-65. PubMed ID: 6598219
    [No Abstract]   [Full Text] [Related]  

  • 3. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
    Mizutani Y; Bonavida B
    Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias.
    Mitrou PS
    Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma.
    Martino S; Decker DA; Hynes HE; Kresge CL
    Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.
    Soulié P; Bensmaïne A; Garrino C; Chollet P; Brain E; Fereres M; Jasmin C; Musset M; Misset JL; Cvitkovic E
    Eur J Cancer; 1997 Aug; 33(9):1400-6. PubMed ID: 9337681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hydrocortisone in the control of nausea and vomiting during CAP therapy].
    Ohwada M; Suzuki M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2119-22. PubMed ID: 2432137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines].
    Perevodchikova NI; Denisov LE; Orel NF; Trofimova NB; Iarygin LM
    Vopr Onkol; 1987; 33(10):73-5. PubMed ID: 3479861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of cis-diamminedichloroplatinum (cis-platinum) CDDP in the treatment of stage III and IV cancers of the ovary (author's transl)].
    Amiel JL; Droz JP; Tursz T; Ayed FB; Gastiaburu J; Rouesse J
    J Gynecol Obstet Biol Reprod (Paris); 1979; 8(1):65-6. PubMed ID: 469203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer.
    Chambers SK; Chambers JT; Kohorn EI; Schwartz PE
    Gynecol Oncol; 1987 Jun; 27(2):233-40. PubMed ID: 3570062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
    Futagami M; Sato S; Sakamoto T; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Sep; 82(3):544-9. PubMed ID: 11520153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer.
    Reed E; Evans MK
    J Natl Cancer Inst; 1990 Mar; 82(5):431-2. PubMed ID: 2304092
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
    Kojima M; Kikkawa F; Oguchi H; Mizuno K; Maeda O; Tamakoshi K; Ishikawa H; Kawai M; Suganuma N; Tomoda Y
    Eur J Cancer; 1994; 30A(6):773-8. PubMed ID: 7917536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of progressive ovarian cancer with cis-platinum and doxorubicin.
    Bloch B
    S Afr Med J; 1984 Jul; 66(1):14-6. PubMed ID: 6539505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumors.
    Martoni A; Tomasi L; Farabegoli G; Giovannini M; Monetti N; Ganzina F; Pannuti F
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):11-7. PubMed ID: 6581974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
    Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
    Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran.
    Markman M; Hoskins WB
    Cancer Invest; 1990; 8(1):113-4. PubMed ID: 2350715
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells.
    Kikuchi Y; Hirata J; Kita T; Imaizumi E; Tode T; Nagata I
    Gynecol Oncol; 1993 Jun; 49(3):365-72. PubMed ID: 8314539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer.
    Postma TJ; Hoekman K; van Riel JM; Heimans JJ; Vermorken JB
    J Neurooncol; 1999; 45(3):241-6. PubMed ID: 10845395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.